235 related articles for article (PubMed ID: 24090664)
1. Insulin analogues may accelerate progression of diabetic retinopathy after impairment of inner blood-retinal barrier.
Kaya A; Kar T; Aksoy Y; Özalper V; Başbuğ B
Med Hypotheses; 2013 Dec; 81(6):1012-4. PubMed ID: 24090664
[TBL] [Abstract][Full Text] [Related]
2. Retinal photocoagulation does not influence intraocular levels of IGF-I, IGF-II and IGF-BP3 in proliferative diabetic retinopathy-evidence for combined treatment of PDR with somatostatin analogues and retinal photocoagulation?
Spranger J; Möhlig M; Osterhoff M; Bühnen J; Blum WF; Pfeiffer AF
Horm Metab Res; 2001 May; 33(5):312-6. PubMed ID: 11440279
[TBL] [Abstract][Full Text] [Related]
3. The effect of insulin and glucose levels on retinal glial cell activation and pigment epithelium-derived fibroblast growth factor-2.
Layton CJ; Becker S; Osborne NN
Mol Vis; 2006 Jan; 12():43-54. PubMed ID: 16446701
[TBL] [Abstract][Full Text] [Related]
4. The role of growth hormone, insulin-like growth factor and somatostatin in diabetic retinopathy.
Wilkinson-Berka JL; Wraight C; Werther G
Curr Med Chem; 2006; 13(27):3307-17. PubMed ID: 17168853
[TBL] [Abstract][Full Text] [Related]
5. [Role of insulin-like growth factor I in the development of diabetic retinopathy].
Gacka M; Adamiec J
Przegl Lek; 2003; 60(9):588-92. PubMed ID: 15065339
[TBL] [Abstract][Full Text] [Related]
6. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.
Meyer-Schwickerath R; Pfeiffer A; Blum WF; Freyberger H; Klein M; Lösche C; Röllmann R; Schatz H
J Clin Invest; 1993 Dec; 92(6):2620-5. PubMed ID: 7504689
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor I (IGF-I) receptor/binding protein in human diabetic epiretinal membranes.
Ulbig MW; Wolfensberger TJ; Hiscott P; Ationu A; Carter ND; Gregor ZJ
Ger J Ophthalmol; 1995 Sep; 4(5):264-8. PubMed ID: 7496335
[TBL] [Abstract][Full Text] [Related]
8. Quantification and localization of the IGF/insulin system expression in retinal blood vessels and neurons during oxygen-induced retinopathy in mice.
Lofqvist C; Willett KL; Aspegren O; Smith AC; Aderman CM; Connor KM; Chen J; Hellstrom A; Smith LE
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1831-7. PubMed ID: 18997086
[TBL] [Abstract][Full Text] [Related]
9. Expression of the growth hormone/insulin-like growth factor axis during Balb/c thymus ontogeny and effects of growth hormone upon ex vivo T cell differentiation.
Kermani H; Goffinet L; Mottet M; Bodart G; Morrhaye G; Dardenne O; Renard C; Overbergh L; Baron F; Beguin Y; Geenen V; Martens HJ
Neuroimmunomodulation; 2012; 19(3):137-47. PubMed ID: 22261974
[TBL] [Abstract][Full Text] [Related]
10. A decrease in retinal progenitor cells is associated with early features of diabetic retinopathy in a model that combines diabetes and hypertension.
Lopes de Faria JM; Silva KC; Boer PA; Cavalcanti TC; Rosales MA; Ferrari AL; Lopes de Faria JB
Mol Vis; 2008 Sep; 14():1680-91. PubMed ID: 18806882
[TBL] [Abstract][Full Text] [Related]
11. [Therapy of diabetic retinopathy with somatostatin analogues].
Lang GE
Ophthalmologe; 2004 Mar; 101(3):290-3. PubMed ID: 15007609
[TBL] [Abstract][Full Text] [Related]
12. Protective factors in diabetic retinopathy: focus on blood-retinal barrier.
Zhang C; Wang H; Nie J; Wang F
Discov Med; 2014 Sep; 18(98):105-12. PubMed ID: 25227751
[TBL] [Abstract][Full Text] [Related]
13. Systemic levels contribute significantly to increased intraocular IGF-I, IGF-II and IGF-BP3 [correction of IFG-BP3] in proliferative diabetic retinopathy.
Spranger J; Bühnen J; Jansen V; Krieg M; Meyer-Schwickerath R; Blum WF; Schatz H; Pfeiffer AF
Horm Metab Res; 2000 May; 32(5):196-200. PubMed ID: 10871161
[TBL] [Abstract][Full Text] [Related]
14. Increased intraocular insulin-like growth factor-I triggers blood-retinal barrier breakdown.
Haurigot V; Villacampa P; Ribera A; Llombart C; Bosch A; Nacher V; Ramos D; Ayuso E; Segovia JC; Bueren JA; Ruberte J; Bosch F
J Biol Chem; 2009 Aug; 284(34):22961-9. PubMed ID: 19473988
[TBL] [Abstract][Full Text] [Related]
15. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.
Ristori C; Filippi L; Dal Monte M; Martini D; Cammalleri M; Fortunato P; la Marca G; Fiorini P; Bagnoli P
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):155-70. PubMed ID: 20739470
[TBL] [Abstract][Full Text] [Related]
16. Modulation of retinal endothelial cell behaviour by insulin-like growth factor I and somatostatin analogues: implications for diabetic retinopathy.
Wilson SH; Davis MI; Caballero S; Grant MB
Growth Horm IGF Res; 2001 Jun; 11 Suppl A():S53-9. PubMed ID: 11527089
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone and a partial mediator of its biological action, insulin-like growth factor I.
Pankov YA
Biochemistry (Mosc); 1999 Jan; 64(1):1-7. PubMed ID: 9986906
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of early postnatal ibuprofen and indomethacin on VEGF, IGF-I, and GH during rat ocular development.
Beharry KD; Modanlou HD; Hasan J; Gharraee Z; Abad-Santos P; Sills JH; Jan A; Nageotte S; Aranda JV
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3036-43. PubMed ID: 16799050
[TBL] [Abstract][Full Text] [Related]
19. An eye on insulin.
Bronson SK; Reiter CE; Gardner TW
J Clin Invest; 2003 Jun; 111(12):1817-9. PubMed ID: 12813016
[TBL] [Abstract][Full Text] [Related]
20. Chronic alcohol consumption, type 2 diabetes mellitus, insulin-like growth factor-I (IGF-I), and growth hormone (GH) in ethanol-treated diabetic rats.
Kim SJ; Ju A; Lim SG; Kim DJ
Life Sci; 2013 Nov; 93(21):778-82. PubMed ID: 24084046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
